Stephen J. Ubl, president and CEO of the Pharmaceutical Research and Manufacturers of America, will discuss the value and promise of personalized medicine at the 12th Annual State of Personalized Medicine Luncheon Address, including the fact that 25 percent of new drugs approved last year were so-called personalized medicine.
Members of the press are invited. Email Chris Wells (at cwells@personalizedmedicinecoalition.org) for more information.
May 25, noon-2 p.m. ET at the National Press Club